Canntab Therapeutics Limited announced earnings results for the second quarter ended November 30, 2018. For the second quarter, the company announced total revenue was CAD 32,438 compared to CAD 7,623 a year ago. Net loss was CAD 787,397 compared to CAD 247,328 a year ago. Basic loss per share was CAD 0.03 compared to CAD 0.01 a year ago. For the half year, total revenue was CAD 64,233 compared to CAD 8,306 a year ago. Net loss was CAD 1.234 million compared to CAD 458,928 a year ago. Basic loss per share was CAD 0.05 compared to CAD 0.02 a year ago.